Delivery Order SPE2DR25D2104-SPE2DR26F3SAB
- Not listed
- The Defense Logistics Agency awarded a $24,528.85 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30, with completion expected by December 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and regularly...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) with a ceiling value of $29,112.52. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The contract is scheduled for completion by December 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $13,012.76 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for supply of RINVOQ ER 15 mg tablets in quantities of 30-unit bottles. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 2, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $15,045.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on November 5, 2025, with completion expected by November 6, 2025. This non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a $23,153.27 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor will perform this...
- The Defense Logistics Agency awarded a $21,799.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of RINVOQ ER 30 mg tablets in units of 30. This competitively awarded, non-set-aside contract is scheduled for completion by December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $7,635.64 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of RINVOQ ER 15 mg tablets in a quantity of 30 units. The contract is valued at $155,311.70 and utilizes firm fixed price terms, with an ultimate completion date of December 2, 2025. This is an unset-aside, competitively awarded delivery order, indicating that AmerisourceBergen competed against other qualified vendors to secure this pharmaceutical supply requirement. The place...
- The Defense Logistics Agency awarded a $17,411.01 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This firm fixed price contract, with an ultimate completion date of December 15, 2025, represents a non-set-aside competitive award for pharmaceutical products to support federal medical procurement needs. The delivery order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $5,057.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This competitively awarded, non-set-aside contract is scheduled for completion by December 16, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's existing contract vehicle with the...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3SABDelivery Order
The Defense Logistics Agency awarded a $9,914.76 delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency covering a wide spectrum of pharmaceutical products, medical devices, and healthcare commodities. Through its DLA Troop Support IDC, AmerisourceBergen supplies medications, vaccines, specialty pharmaceuticals, and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains. The company's consistent receipt of competitively awarded, firm fixed-price delivery orders demonstrates its capability to meet federal procurement requirements and deliver critical pharmaceutical products to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 12/18/25 |